PALI which I own is seeing a lot of action yesterday and this morning. It was up over 57% yesterday on big volume and is up a good bit more this morning. It had been up more but has given back some. They have received fast track approval for a drug that prevents adhesions after bowel surgery and may have other uses. A brokerage company put a buy rating on it with a $50.00 price target . I find that to be quite a stretch since the stock is a little over $3.00 My cost is $4.29 so I would be very happy with $10.00. The stock ran up almost to $10.00 a few months ago but gave back the gains. My cost was $10.00 . I bough more last week at $1.77 to bring my cost down.
